Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – 15 to 23 amino acid residues in defined sequence
Patent
1993-02-19
1996-09-03
Kight, John
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
15 to 23 amino acid residues in defined sequence
530300, 530322, 424 93, 424 935, 424 94, 424 943, 424 96, A61K 3800, A61K 5100, C07K 200
Patent
active
055525253
ABSTRACT:
This invention relates to reagents, radiolabeled reagents and methods for producing such reagents and radiolabeled reagents. Specifically, the invention relates to technetium-99m (Tc-99m) labeled peptides that specifically bind to inflammatory sites in vivo, methods and kits for making such peptides, and methods for using such peptides to image sites of infection and inflammation in a mammalian body.
REFERENCES:
patent: 4057617 (1977-11-01), Abramovici et al.
patent: 4385046 (1983-05-01), Milbrath et al.
patent: 4444690 (1984-04-01), Fritzberg
patent: 4935223 (1990-06-01), Phillips
patent: 4986979 (1991-01-01), Morgan, Jr. et al.
patent: 5198424 (1993-03-01), McEver
patent: 5266562 (1993-11-01), Mukherjee et al.
patent: 5308603 (1994-05-01), Thakur
patent: 5376356 (1994-12-01), Morgan, Jr.
Takefumi et al, Molecular & Cellular Biology, pp. 898-904, (1987).
Deuel et al., "Amino acid sequence of human platelet factor 4", 1977, Proc. Natl. Acad. Sci. USA 74:2256-2258.
Niedel and Cuatrecasas, 1980, "Formyl Peptide Chemotactic Receptors of Leukocytes and Macrophages", in Curr. Top. Cell. Reg. 17: 137-170.
Deuel et al., "Platelet factor 4 is chemotactic for neutrophils and monocytes", 1981, Proc. Natl. Acad. Sci. USA 78:4584-4587.
Zoghbi et al., "Selective cell labeling: A potential radioactive agent for labeling human neutrophils", 1981, J. Nucl. Med. 22:32 (Abst).
Jiang et al., "Localization of abscess with an iodinated synthetic chemotactic peptide", 1982, Nuklearmedizin 21:110-113.
Osterman et al., "The carboxyl-terminal tridecapeptide of platelet factor 4 is a potent chemotactic agent for monocytes", 1982, Biochem. Biophys. Res. Comm. 107:130-135.
Holt & Niewiarowski, "Biochemistry of .alpha.-granule proteins", 1985, Sem. Hematol. 22:151-163.
Goldman et al., "Inhibition of human neutrophil receptor-mediated uptake of N-formyl-mey-leu-phe by platelet factor 4(59-70)", 1985, Immunol. 54:163-171.
Loscalzo et al., "The interaction of platelet factor 4 and glycosaminoglycans", 1985, Arch. Biochem. Biophys. 240:446-455.
Bebawy et al., "In vitro effects of platelet factor 4 on normal human neutrophil functions", 1986, J. Leukocyte Biol. 39:423-434.
Wilkinson, "Chemotactic factors: An overview", 1988, Meth. Enzymol. 162: 127-132.
Vorne et al., "Technetium-99m HM-PAO-labeled leukocytes in detection of inflammatory lesions: Comparison with gallium-67 citrate", 1989, J. Nucl. Med. 30: 1332-1336.
LaMuraglia et al., "Utility of the indium 111-labeled human immunoglobulin G scan for the detection of focal vascular graft infection", 1989, J. Vasc. Surg. 10: 20-28.
Maione et al., "Inhibition of angiogenesis by recombinant human platelet factor 4 and related peptides", 1989, Science 247:77-79.
Lind et al., "Immunoscintigraphy of inflammatory processes with a technietium-99m-labeled monoclonal antigranulocyte antibody (MAb BW 250183)", 1990, J. Nucl. Med. 31: 417-423.
Fischman et al., "Imaging focal sites of bacterial infection in rats with indium-111-labeled chemotactic peptide analogs", 1991, J. Nucl. Med. 32: 483-491.
Diatech Inc.
Kight John
Leary Louise
LandOfFree
Technetium-99m labeled peptides for imaging inflammation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Technetium-99m labeled peptides for imaging inflammation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Technetium-99m labeled peptides for imaging inflammation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1951071